AHA: Survival Odds Up With Statins Before Cardiac Arrest

Share this content:
AHA: Survival Odds Up With Statins Before Cardiac Arrest
AHA: Survival Odds Up With Statins Before Cardiac Arrest

MONDAY, Nov. 14, 2016 (HealthDay News) -- The odds of surviving cardiac arrest appear higher for patients who've been taking statins, according to findings presented at the annual meeting of the American Heart Association, held from Nov. 12 to 16 in New Orleans.

Ping-Hsun Yu, M.D., a researcher from the National Taiwan University Hospital and College of Medicine in New Taipei City, and colleagues divided the medical records of almost 138,000 patients according to whether or not they had used statins for 90 days within the year before their cardiac arrest. The researchers also accounted for gender, age, other medical problems, number of hospitalizations, post-resuscitation factors, and other variables.

Those already using statins were about 19 percent more likely to survive to hospital admission and 47 percent more likely to be discharged. They were also found to be 50 percent more likely to be alive a year later. The greatest survival benefit from statins was seen in patients with type 2 diabetes, Yu's team said.

"When considering statin use for patients with high cholesterol, the benefit of surviving sudden cardiac arrest should also be considered, as statin use before cardiac arrest might improve outcomes of those patients," Yu told HealthDay.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »